Table 4.
Diabetes treatment regimens in the PANORAMA study population
| Treatment regimen | n (%) |
| No diet, no orals, no injectables (no available data) | 10 (2.7) |
| Only diet and/or exercise | 20 (5.3) |
| Only OADs | 244 (65.1) |
| On oral plus insulin | 63 (16.8) |
| Only on insulin | 28 (7.5) |
| On GLP-1 analogues ± insulin1 | 10 (2.7) |
| Oral hypoglycaemic agents | 316 (84.3) |
| Sylphonylureas | 121 (32.3) |
| Meglitinides/Glinides | 12 (3.2) |
| Biguanides | 275 (73.3) |
| Thiazolidinediones | 41 (10.9) |
| DPP-4 inhibitors | 94 (25.1) |
| Alpha glucosidase inhibitors | 13 (3.5) |
| Fixed-dose combinations | 46 (12.3) |
| Thiazolidinediones + metformin | 3 (6.5) |
| DPP4 inhibitors + metformin | 43 (93.5) |
1
One patient receiving a GLP-1 analogue and insulin was classified in the latter category making the total number of patients 91 when the number should have been 92. OAD: Oral anti-diabetes drugs.